General
Preferred name
L-NIL
Synonyms
L-NIL hydrochloride ()
L-N6-(1-Iminoethyl)lysine dihydrochloride ()
L-NIL dihydrochloride ()
L-NIL (hydrochloride) ()
P&D ID
PD071200
CAS
159190-45-1
150403-89-7
53774-63-3
Tags
available
drug candidate
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION L-NIL is a selective nitric oxide synthase (iNOS) inhibitor that reverses burn-induced activation of glycogen synthase kinase-3?? in rat skeletal muscle and may slow the progression of squamous cell carcinoma lung.
DESCRIPTION L-NIL is a relatively selective inhibitor of iNOS. It prevented ischemic-induced renal microvascular hypoxia via inhibiting iNOS-dependent early changes in renal oxygenation which disrupts the balance between microvascular oxygen supply and Vo(2)(ren). (BOC Sciences Bioactive Compounds)
DESCRIPTION Selective iNOS inhibitor (Tocriscreen Total)
DESCRIPTION L-NIL hydrochloride is a nitric oxide synthase inhibitor with IC50 value of 3.3 μM. (BOC Sciences Bioactive Compounds)
DESCRIPTION L-NIL is a selective nitric oxide synthase (iNOS) inhibitor that reverses burn-induced activation of glycogen synthase kinase-3β in rat skeletal muscle and may slow the progression of squamous cell carcinoma lung. (TargetMol Bioactive Compound Library)
Cell lines
2
Organisms
0
Compound Sets
10
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugMAP
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
TargetMol Bioactive Compound Library
Tocriscreen Total
External IDs
49
Properties
(calculated by RDKit )
Molecular Weight
187.13
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
4
Rotatable Bonds
6
Ring Count
0
Aromatic Ring Count
0
cLogP
0.16
TPSA
99.2
Fraction CSP3
0.75
Chiral centers
1.0
Largest ring
0.0
QED
0.27
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
NO Synthase
Inos
NOS1, NOS2, NOS3
Member status
member
MOA
Inducible Nitric Oxide Synthase (NOS-2) Inhibitors
nitric oxide synthase inhibitor
Pathway
Immunology/Inflammation
Source data